Literature DB >> 16520804

Mechanisms of disease: breast tumor pathogenesis and the role of the myoepithelial cell.

Sanford H Barsky1, Nina J Karlin.   

Abstract

Breast cancer and precancer cells are influenced by important paracrine regulation from the breast microenvironment, which might be as great a determinant of breast cancer behavior as the specific oncogenic or tumor-suppressive alterations occurring within malignant breast cells. Myoepithelial cells exert profound effects on breast tumor cell behavior, and lie in juxtaposition to abnormally proliferating breast epithelial cells in precancerous disease states such as ductal carcinoma in situ (DCIS). Myoepithelial cells also form a natural border separating breast epithelial cells from stromal angiogenesis. These anatomical relationships suggest that myoepithelial cells might inhibit both the progression of DCIS to invasive breast cancer, and carcinoma-induced angiogenesis. Our ability to study myoepithelial cells has been fostered by recent technical advances in cell selection and sorting procedures, improved selective media, and high throughput technologies, which are able to assess the gene and protein expression profiles within cells. In addition, the establishment of a number of immortalized cell lines and xenografts of myoepithelial cells derived from benign human myoepithelial tumors of diverse sources has provided a self-renewing cell source through which to study the phenotype of myoepithelial cells. Studies of primary and immortalized myoepithelial cell lines indicate that these cells exhibit a natural tumor suppressor function. Functional studies show that these cells have anti-invasive and antiangiogenic phenotypes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16520804     DOI: 10.1038/ncponc0450

Source DB:  PubMed          Journal:  Nat Clin Pract Oncol        ISSN: 1743-4254


  20 in total

1.  Hypoxia-induced nitric oxide release by luminal cells stimulates proliferation and uPA secretion of myoepithelial cells in a bicellular murine mammary tumor.

Authors:  Martin Alejandro Krasnapolski; Catalina Lodillinsky; Elisa Bal De Kier Joffé; Ana María Eiján
Journal:  J Cancer Res Clin Oncol       Date:  2015-02-17       Impact factor: 4.553

2.  SLIT/ROBO1 signaling suppresses mammary branching morphogenesis by limiting basal cell number.

Authors:  Hector Macias; Angel Moran; Yazeed Samara; Melissa Moreno; Jennifer E Compton; Gwyndolen Harburg; Phyllis Strickland; Lindsay Hinck
Journal:  Dev Cell       Date:  2011-06-14       Impact factor: 12.270

3.  The EGF signaling pathway influences cell migration and the secretion of metalloproteinases by myoepithelial cells in pleomorphic adenoma.

Authors:  Natalia Festugatto Navarini; Vera Cavalcanti de Araújo; Amy Louise Brown; Fabrício Passador-Santos; Isabela Fernandes de Souza; Marcelo Henrique Napimoga; Ney Soares Araújo; Elizabeth Ferreira Martinez
Journal:  Tumour Biol       Date:  2014-09-18

4.  Sustained activation of the HER1-ERK1/2-RSK signaling pathway controls myoepithelial cell fate in human mammary tissue.

Authors:  Lejla Pasic; T S Karin Eisinger-Mathason; Bisi T Velayudhan; Christopher A Moskaluk; David R Brenin; Ian G Macara; Deborah A Lannigan
Journal:  Genes Dev       Date:  2011-08-01       Impact factor: 11.361

5.  Breast cancer risk factor associations differ for pure versus invasive carcinoma with an in situ component in case-control and case-case analyses.

Authors:  Melanie Ruszczyk; Gary Zirpoli; Shicha Kumar; Elisa V Bandera; Dana H Bovbjerg; Lina Jandorf; Thaer Khoury; Helena Hwang; Gregory Ciupak; Karen Pawlish; Pepper Schedin; Patricia Masso-Welch; Christine B Ambrosone; Chi-Chen Hong
Journal:  Cancer Causes Control       Date:  2015-11-30       Impact factor: 2.506

6.  Effect of epithelial growth factor on matrix metalloproteinase-2 and E-cadherin/β-catenin expression in an in situ model of tumorigenesis.

Authors:  Natalia Festugatto Navarini; Vera Cavalcanti De Araújo; Marcelo Sperandio; Marcelo Henrique Napimoga; Lucas Novaes Teixeira; Ney Soares De Araújo; Elizabeth Ferreira Martinez
Journal:  Oncol Lett       Date:  2017-06-30       Impact factor: 2.967

7.  Estrogen-induced CCN1 is critical for establishment of endometriosis-like lesions in mice.

Authors:  Yuechao Zhao; Quanxi Li; Benita S Katzenellenbogen; Lester F Lau; Robert N Taylor; Indrani C Bagchi; Milan K Bagchi
Journal:  Mol Endocrinol       Date:  2014-12

Review 8.  Progression from ductal carcinoma in situ to invasive breast cancer: revisited.

Authors:  Catherine F Cowell; Britta Weigelt; Rita A Sakr; Charlotte K Y Ng; James Hicks; Tari A King; Jorge S Reis-Filho
Journal:  Mol Oncol       Date:  2013-07-12       Impact factor: 6.603

9.  GT198 Expression Defines Mutant Tumor Stroma in Human Breast Cancer.

Authors:  Zheqiong Yang; Min Peng; Liang Cheng; Kimya Jones; Nita J Maihle; Nahid F Mivechi; Lan Ko
Journal:  Am J Pathol       Date:  2016-03-18       Impact factor: 4.307

Review 10.  Ductal Carcinoma in Situ Biomarkers in a Precision Medicine Era: Current and Future Molecular-Based Testing.

Authors:  Kevin Shee; Kristen E Muller; Jonathan Marotti; Todd W Miller; Wendy A Wells; Gregory J Tsongalis
Journal:  Am J Pathol       Date:  2018-10-29       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.